Bio Immune
Bio Immune
Bio-Immune™ is a supramolecular inclusion complex of bioactive Andrographolide obtained from Andrographis paniculata. It shows excellent anti-viral and immunomodulation properties. It has been in-vitro tested against the SARS CoV2 virus with 99.91% inhibition of virus replication. Bio-Immune can be safely used in oral or nasal dosage formats
- Description
- Supporting Literature
What makes Bio-ImmuneTM superior to other Andrographolide based products:
- Offers significantly higher water solubility and bioavailability in comparison to conventional Andrographolide (95%)
- Enhanced half life (6.38 hours) as compared to conventional Andrographolide
- The only Andrographolide based formula in the market that is suitable for Oral as well as pulmonary use
Health Benefits: Useful in the management of various upper respiratory tract infections
Studies Conducted:
In-vitro Test: Bio-ImmuneTM has been in-vitro tested against the SARS CoV2 virus. In an apple to apple comparison with anti-viral drug Remdesivir, the Bio-ImmuneTM was found to be effective in inhibiting the replication of virus by 99.91% in 48 hours. The study has been published in journal and has also been shortlisted by WHO
- Link to the published paper: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351079
- Link to the WHO database: https://pesquisa.bvsalud.org/global-literature-on-novel-coronavirus-2019-ncov/resource/pt/covidwho-1531288
Safety Study: Acute Toxicity Study and Sub-acute Toxicity Studies have been conducted for both oral and nasal dosages for Bio-ImmuneTM
- Link to safety/toxicity study: https://www.hindawi.com/journals/tswj/2022/6224107
Dosage:
- Oral: 100 mg x 2 / Day
- Nasal: 0.18 mg /nostril x 2 / Day